Want to become the sole advertiser on this website? Just £500 GBP / month.
Contact us today.
Borrow Fee Spike USSLS

SELLAS Life Sciences (SLS) Borrow Fee Spike

SELLAS Life Sciences Group (SLS) is currently experiencing some of the highest borrow fees among stocks with significant short value.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk October 2, 20261 min read
Company
SELLAS Life Sciences Group
Borrow Fee
High
Short % Float
0%
Days to Cover
0

Borrow Fee Surge in SLS

SELLAS Life Sciences Group (SLS) has been identified as having one of the highest borrow fees for stocks with a short value exceeding $1 million. High borrow fees are a primary indicator of share scarcity and strong demand from short sellers to maintain or increase their positions. When borrow fees spike, it often suggests that the supply of lendable shares is tightening, which can create a difficult environment for existing shorts and potentially lead to a short squeeze if the stock price begins to appreciate. Investors should keep a close eye on the daily borrow rate and share availability, as these metrics are often the first to move before a significant price reversal.

Source

Signal data sourced from Interactive Brokers. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Borrow Fee#SLS#Biotech

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog